Revolution Medicines, Inc., a global commercial-stage oncology company dedicated to discovering, developing and delivering innovative medicines for patie...
Immuneering Corporation, a late-stage clinical oncology company focused on keeping cancer patients alive and helping them thrive, shared comments followi...
Thermo Fisher Scientific, the world leader in serving science, introduced the Thermo Scientific Orbitrap Isora Mass Spectrometer and Orbitrap Isora Pro M...
Vector Science and Therapeutics Corp. ("Vector" or the "Company") is pleased to announce that the Company has entered into an investo...
Caliway Biopharmaceuticals, a clinical-stage biopharmaceutical company developing innovative small-molecule therapeutics, announced two major clinical mi...
SciSparc Ltd.(“Company” or “SciSparc”), announced that its subsidiary, NeuroThera Labs Inc. (TSXV: NTLX) ("NeuroThera"), a ...
Nanjing Leads Biolabs Co., Ltd. (“Leads Biolabs” or the “Company,” announced that Opamtistomig (LBL-024), the Company&rsquo...
Johnson & Johnson announced that the European Commission (EC) has approved an indication extension for TECVAYLI®(teclistamab) in combination with...
Orum Therapeutics(“Orum” or the “Company”), a biotechnology company pioneering the field of degrader-antibody conjugates (DACs), ...
GENGLYCOS is the first gene therapy approval, and fifth FDA approval overall, for the company Approval provides a long-awaited first-ever option to redu...
Aizen Therapeutics, an AI-native biotechnology company focused on building oral biologics, announced a multi-program collaboration with a San Diego-based...
Skye Bioscience, Inc., and Redx Pharma Limited (“Redx”), a U.K. based, privately-held clinical-stage biotechnology company focused on develop...
Marks Third NMPA Approval in China for an Ivonescimab-Containing Regimen NMPA Approval Based on HARMONi-6 Clinical Trial Conducted by Akeso in China ...
NurExone Biologic Inc. ("NurExone" or the "Company") (TSXV: NRX, OTCQB: NRXBF, FSE: J90), a biotechnology company developing exosome-based regenerative t...
© 2026 Biopharma Boardroom. All Rights Reserved.
